DermTech, Inc. (DMTK)

NASDAQ: DMTK · IEX Real-Time Price · USD
-0.13 (-3.42%)
Mar 30, 2023, 10:19 AM EDT - Market open

Total Valuation

DermTech has a market cap or net worth of $107.20 million. The enterprise value is $37.02 million.

Market Cap 107.20M
Enterprise Value 37.02M

Important Dates

The next earnings date is Tuesday, May 2, 2023, after market close.

Estimated Earnings Date May 2, 2023
Ex-Dividend Date n/a

Share Statistics

DermTech has 30.37 million shares outstanding. The number of shares has increased by 4.00% in one year.

Shares Outstanding 30.37M
Shares Change (YoY) +4.00%
Shares Change (QoQ) +0.50%
Owned by Insiders (%) 8.15%
Owned by Institutions (%) 28.18%
Float 26.58M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 7.63
Forward PS 2.40
PB Ratio 0.84
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.55
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.70, with a Debt / Equity ratio of 0.42.

Current Ratio 8.70
Quick Ratio 8.56
Debt / Equity 0.42
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -69.70% and return on invested capital (ROIC) is -100.40%.

Return on Equity (ROE) -69.70%
Return on Assets (ROA) -54.80%
Return on Capital (ROIC) -100.40%
Revenue Per Employee $56,933
Profits Per Employee -$457,580
Employee Count 255
Asset Turnover 0.07
Inventory Turnover 12.40


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -75.67% in the last 52 weeks. The beta is 2.58, so DermTech's price volatility has been higher than the market average.

Beta (1Y) 2.58
52-Week Price Change -75.67%
50-Day Moving Average 4.45
200-Day Moving Average 4.42
Average Volume (30 Days) 738,021

Short Selling Information

The latest short interest is 3.20 million, so 10.54% of the outstanding shares have been sold short.

Short Interest 3.20M
Short Previous Month 3.12M
Short % of Shares Out 10.54%
Short % of Float 12.04%
Short Ratio (days to cover) 6.44

Income Statement

In the last 12 months, DermTech had revenue of $14.52 million and -$116.68 million in losses. Loss per share was -$3.88.

Revenue 14.52M
Gross Profit 647,000
Operating Income -118.17M
Pretax Income -116.68M
Net Income -116.68M
EBITDA -112.22M
EBIT -116.68M
Loss Per Share -$3.88
Full Income Statement

Balance Sheet

The company has $129.66 million in cash and $55.83 million in debt, giving a net cash position of $73.83 million or $2.43 per share.

Cash & Cash Equivalents 129.66M
Total Debt 55.83M
Net Cash 73.83M
Net Cash Per Share $2.43
Equity / Book Value 132.35M
Book Value Per Share 4.36
Working Capital 120.40M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$95.26 million and capital expenditures -$3.31 million, giving a free cash flow of -$98.57 million.

Operating Cash Flow -95.26M
Capital Expenditures -3.31M
Free Cash Flow -98.57M
FCF Per Share -$3.28
Full Cash Flow Statement


Gross margin is 4.46%, with operating and profit margins of -813.92% and -803.71%.

Gross Margin 4.46%
Operating Margin -813.92%
Pretax Margin -803.71%
Profit Margin -803.71%
EBITDA Margin -772.99%
EBIT Margin -803.71%
FCF Margin -678.92%

Dividends & Yields

DermTech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -105.27%
FCF Yield -88.93%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -4.00%
Shareholder Yield -4.00%
Dividend Details

Analyst Forecast

The average price target for DermTech is $7.48, which is 112.20% higher than the current price. The consensus rating is "Buy".

Price Target $7.48
Price Target Difference 112.20%
Analyst Consensus Buy
Analyst Count 13
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on August 30, 2019. It was a reverse split with a ratio of 1:2.

Last Split Date Aug 30, 2019
Split Type Reverse
Split Ratio 1:2